重症肌无力

zhònɡ zhènɡ jī wú lì
  • myasthenia gravis;gravis myasthenia
重症肌无力重症肌无力
  1. 单纤维肌电图jitter值和重症肌无力病情变化的相关性

    Correlation of variation in Jitter and severity changes of myasthenia gravis

  2. 目的对伴心脏、肝脏损害,瞳孔不等,听力障碍,手足血管舒缩功能及皮肤营养障碍和阳痿等少见症状的重症肌无力(MG)患者的特点进行分析,提出诊断和鉴别诊断的方法。

    Objective To propose a method for diagnosis and differential diagnosis of myasthenia gravis ( MG ) with heart and liver injury , anisocoria , dysaudia , impatience etc.

  3. 重症肌无力患者胸腺CT表现与年龄的关系

    The thymus CT manifestation in myasthenia gravis patients relative to ages

  4. 重症肌无力B细胞免疫应答涉及乙酰胆碱受体的全部亚单位

    The B Cell Repertoire in Myasthenia Gravis Includes All Four Acetylcholine Receptor Subunits

  5. 重症肌无力合并胸腺瘤的CT及血清相关抗体

    Thymus CT Scan and Thymoma Associated Antibodies in Myasthenia Gravis with Thymoma

  6. 重症肌无力的P(300)研究

    P 300 studies on myasthenia gravis

  7. 目的重症肌无力(MG)是一种自身免疫病。

    Objective Myasthenia gravis ( MG ) is an autoimmune disease .

  8. 儿童眼肌型重症肌无力胸腺MRI表现

    MRI manifestations of thymus in children with ocular-muscular type myasthenia gravis

  9. 目的了解胸腺内B淋巴细胞与重症肌无力发生的关系。

    Objective To assess the distribution and clinical significance of B-lymphocyte subgroup CD20 in patients with myasthenia gravis .

  10. 重症肌无力患者外周血CD4~+CD(25)~(high)T细胞及其动态观察

    Dynamic study of circulating CD_4 ~ + CD_ ( 25 ) ~ ( high ) T cells in myasthenia gravis

  11. 目的筛选及鉴定重症肌无力(MG)相关基因。

    Objective To screen and identify the gene related to myasthenia gravis ( MG ) .

  12. 重症肌无力(MG)是神经肌肉接头损害为主的自身免疫性疾病,其发病机理仍不清楚,一般认为遗传和环境因素共同作用的结果。

    Objective : Myasthenia gravis ( MG ) is a neuromuscular disorder of autoimmune disease .

  13. 不同年龄组重症肌无力患者胸腺MRI表现

    MRI manifestations of thymus in myasthenia gravis ( MG ) patients in various age groups

  14. 探讨泼尼松治疗重症肌无力(MG)免疫学机制。

    The immunological mechanism of prednisone in the treatment of myasthenia gravis ( MG ) was studied .

  15. 伴重症肌无力的胸腺瘤HLA类分子表达强度分析

    Expression of HLA molecules antigens in cortical thymoma associated with myasthenia gravis

  16. 重症肌无力患者胸腺组织中Bcl-2和Fas表达水平的研究

    The level of BCL-2 and FAS expression in thymic tissue of myasthenia gravis

  17. 重症肌无力胸腺细胞凋亡与Fas基因表达的研究

    Apoptosis of thymocytes and expression of Fas / FasL in MG thymus

  18. 大鼠重症肌无力模型与NO和NOS的关系

    Alteration of NO and NOS myasthenic model of CNS dysfunction in rats

  19. 结论TNF基因多态性与胸腺瘤发病及胸腺瘤发生重症肌无力相关。

    Conclusion : TNF gene may be correlated with the susceptibility of thymoma and thymoma with MG .

  20. 目的探讨胸腺瘤合并重症肌无力(MG)扩大根治术术式的疗效。

    Objective : To investigate the effect of thymomas with myasthenia gravis ( MG ) treated by extensive radical resection .

  21. 目的观察冰试验在重症肌无力(MG)上睑下垂诊断中的价值。

    Objective To investigate the value of ice test in the diagnosis of ptosis of myasthenia gravis ( MG ) .

  22. 重症肌无力患者病情变化对单纤维肌电图jitter值的影响

    Influence of the Change of Myasthenia Gravis Severity on Jitter Values

  23. Jitter测定在评价重症肌无力病情严重程度中的意义

    Significance of Jitter Measurement in Evaluating the Severity of Myasthenia Gravis

  24. 霉酚酸吗啉乙酯治疗重症肌无力合并原发性CNS淋巴瘤

    Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil

  25. 重症肌无力患者血清中SOD、MDA、NOS水平及其临床意义

    The Level and Clinical Significance of SOD , MDA , NOS in Serums of MG Patients

  26. 目的探讨重症肌无力(MG)危象的诱发因素、延长气管插管的因素以及并发症、病死率。

    Objective To evaluate the precipitating factor , mortality , complications of myasthenia gravis crisis and risk factors of prolonged intubation .

  27. 目的:探讨重症肌无力(MG)时胸腺微环境的变化及其发病机制。

    Purpose To inquire the changes of thymus microenvironment in myasthenia gravis ( MG ) patients and the pathogenesis of MG .

  28. 重症肌无力患者胸腺内B淋巴细胞亚群CD20的分布及临床意义

    Distribution of B lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis

  29. 黄芪复方对重症肌无力IFN-γ及其mRNA表达水平的影响

    The Regulation Effects of HuangQi Compound on the level of IFN - γ and it 's mRNA in Myasthenia Gravis Patients

  30. 目的:研究CD5+B细胞在重症肌无力(MG)发病中的作用。

    Aim : To study the role of CD5 + B cells in the pathogenic mechanism of myasthenia gravis ( MG ) .